USA Rare Earth, Inc. Releases Detailed Pro Forma Financials Following Key Corporate Events: Major M&A, Government Funding, and Strategic Agreements Set to Transform Company
Introduction
USA Rare Earth, Inc. (“USAR” or “the Company”) has released its unaudited pro forma condensed combined financial statements as of March 31, 2026, presenting a transformative period for the Company. The document outlines the impact of several major transactions, including a high-profile merger, a massive private placement, government support under the CHIPS Act, and other critical agreements. These developments are highly significant and may have material effects on the Company’s future share value. Below, we break down the key points, strategic implications, and critical details for investors.
Key Events and Transactions
1. Merger with Serra Verde Rare Earths Ltd. (SVRE)
- Structure: On April 19, 2026, USAR agreed to merge with SVRE, with SVRE becoming a wholly owned subsidiary of USAR. The merger consideration comprises 126,849,307 shares of USAR common stock and \$300 million in cash.
- Equity Compensation: All outstanding SVRE warrants, RSUs, SARs, and certain options are to be exercised or converted into merger consideration. Performance-vesting options are converted into USAR RSUs.
- Valuation: The equity consideration is valued using USAR’s share price of \$22.47 as of June 5, 2026, putting the total estimated purchase consideration at \$3.15 billion, with \$991.8 million recognized as goodwill.
2. Strategic Private Placement
- Details: On January 26, 2026, USAR completed a private placement of 69,767,442 shares, raising \$1.5 billion at \$21.50 per share.
- Implication: This significantly boosts liquidity, strengthening USAR’s balance sheet for future investments and operations.
3. U.S. Government Funding – CHIPS Act and Debt Package
- Letters of Intent Signed: USAR entered into non-binding agreements with the U.S. Department of Commerce (DOC) for approximately \$1.6 billion, including \$277 million in direct funding and \$1.3 billion in senior secured debt (15-year term, UST + 150 bps).
- Securities Issuance to DOC: As a deal sweetener, USAR agreed to issue 16,132,790 shares to the DOC and grant a warrant to purchase 17,600,584 shares at \$17.17 per share.
- Contingency: Disbursement is subject to project, financing, and commercial milestones. As of the pro forma filing, no proceeds have been drawn.
4. DFC Financing and Warrants
- Retained Finance Agreement: On January 21, 2026, SVRE secured a \$565 million long-term debt facility from the U.S. International Development Finance Corporation (DFC).
- Incremental Loan: An additional \$100 million tranche was formalized. DFC received warrants for a combined 12% fully diluted equity interest, automatically exercised upon closing the Merger, extinguishing the loan.
5. Long-Term Offtake Agreement
- Scope: SVRE subsidiary entered into a 20-year offtake agreement with a U.S. government-backed SPV and private capital for 100% of “phase one” rare earth production from the Pela Ema project.
- Pricing: Based on annual floor prices with upside sharing; SVRE retains 70% of amounts above floor price.
- Start Date and Conditions: Scheduled to start after certain milestones are met, with a long-stop date of June 12, 2026.
6. Issuance of Earnout Shares
- Trigger and Details: USAR agreed to issue up to 10.1 million shares to certain legacy shareholders in two tranches, based on market price targets (\$15, then \$20 for 20 out of 30 trading days).
- Accounting: These were initially classified as liabilities and remeasured at fair value, then reclassified as equity upon issuance.
Pro Forma Financial Impact
Balance Sheet Highlights (As of March 31, 2026, Pro Forma)
- Total Assets: \$6.88 billion
- Cash & Equivalents: \$1.66 billion (post-cash merger consideration and incremental loan adjustments)
- Goodwill: \$1.13 billion (reflecting the premium paid for SVRE)
- Property, Plant & Equipment: \$3.23 billion (primarily development-stage mining and processing assets)
- Liabilities: \$1.66 billion (including long-term debt, royalty obligations, and deferred tax liabilities)
- Equity: \$5.22 billion (reflecting new share issuances, including DOC and earnout shares)
Income Statement (Three Months Ended March 31, 2026, Pro Forma)
- Revenue: \$6.3 million (combined USAR and SVRE)
- Operating Loss: \$(53.1) million
- Net Loss: \$(74.4) million; Net Loss per Share: \$(0.21) based on 349.6 million shares
The company remains in a heavy investment and development phase, with significant R&D, SG&A, and financing expenses. However, the strengthened capital base and government partnerships position USAR for future revenue growth as production comes online.
Key Shareholder Considerations and Price-Sensitive Information
- Government Backing: Substantial support and funding from the U.S. government (both DOC and DFC) underlines the strategic importance of USAR’s rare earths business to national policy, potentially de-risking the investment and supporting future share value.
- Share Dilution: Multiple large equity issuances (Merger, Private Placement, DOC shares, Earnout shares) will materially increase the outstanding share count, which could dilute existing shareholders but also strengthens the balance sheet and strategic partnerships.
- Potential for Share Price Volatility: The value of the merger consideration is sensitive to USAR’s share price. For example, a 25% increase in share price increases the total purchase consideration and goodwill by over \$700 million.
- Offtake Agreement: Securing 100% sales for its initial production phase underpins future cash flows but also means the company is highly leveraged to successful project delivery and maintaining government relationships.
- Deferred Financing and Warrants: The DOC and DFC will hold substantial equity stakes and warrants, which could be a future source of dilution if exercised.
- Non-Recurring Expenses: The Company expects \$113 million in transaction costs related to these deals, which will impact near-term earnings but are not expected to recur.
- Major Development Phase: The primary mining and processing assets are still in development, with commercial production expected to commence in 2027.
Summary for Investors
USAR is undergoing a transformative period, marked by a blockbuster merger, extensive government backing, and strategic agreements that underpin its long-term vision to become a leading U.S.-based rare earths provider. The combination of financial strength, strategic partnerships, and long-term offtake agreements substantially de-risks project execution and opens the door to significant future growth. However, the company faces near-term losses, share dilution, and is exposed to execution risks as it seeks to bring its development-stage assets into commercial operation.
Disclaimer
This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities. All information is based on unaudited pro forma financial statements and may be subject to significant change as actual transactions are finalized and audited. Investors should perform their own due diligence and consult with financial advisors before making investment decisions.
